 NEW YORK, April 29, 2021 PRNewswire -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aquestive Therapeutics, Inc. NASDAQ: AQST between December 2, 2019 and September 25, 2020, inclusive the Class Period, of the important April 30, 2021 lead plaintiff deadline. SO WHAT: If you purchased Aquestive securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. 